Nimrod Goldshtrom

Nimrod Goldshtrom

Auto-generated profile, based on publicly available information

Nimrod Goldshtrom

Columbia University Irving Medical Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
THThomas Hays
Thomas Hays
RHRebecca Hernan
Rebecca Hernan
MDMichele Disco
Michele Disco
EGEmily L. Griffin
Emily L. Griffin
NGNimrod Goldshtrom
Nimrod Goldshtrom
WCWendy K. Chung
Wendy K. Chung
BACKGROUND: Rapid genome sequencing (rGS) has been shown to improve care of critically ill infants. Congenital heart disease (CHD) is a leading cause of infant mortality and is often caused by genetic disorders, yet the utility of rGS has not been prospectively studied in this population. METHODS: We conducted a prospective evaluation of rGS to improve the care of infants with complex CHD in our cardiac neonatal intensive care unit. RESULTS: In a cohort of 48 infants with complex CHD, rGS diagnosed 14 genetic disorders in 13 (27%) individuals and led to changes in clinical management in 8 (62%) cases with diagnostic results. These included 2 cases in whom genetic diagnoses helped avert intensive, futile interventions before cardiac neonatal intensive care unit discharge, and 3 cases in whom eye disease was diagnosed and treated in early childhood. CONCLUSIONS: Our study provides the first prospective evaluation of rGS for infants with complex CHD to our knowledge. We found that rGS diagnosed genetic disorders in 27% of cases and led to changes in management in 62% of cases with diagnostic results. Our model of care depended on coordination between neonatologists, cardiologists, surgeons, geneticists, and genetic counselors. These findings highlight the important role of rGS in CHD and demonstrate the need for expanded study of how to implement this resource to a broader population of infants with CHD.

1 March 2021 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
FKFaith Kim
Faith Kim
DBDavid A. Bateman
David A. Bateman
NGNimrod Goldshtrom
Nimrod Goldshtrom
RSRakesh Sahni
Rakesh Sahni
JWJen Tien Wung
Jen Tien Wung
AWAaron Wallman-Stokes
Aaron Wallman-Stokes

30 January 2023 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
FKFaith Kim
Faith Kim
DBDavid A. Bateman
David A. Bateman
NGNimrod Goldshtrom
Nimrod Goldshtrom
JSJean-Ju Sheen
Jean-Ju Sheen
DGDonna Garey
Donna Garey

27 August 2020 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Open access
PDF file
NGNimrod Goldshtrom
Nimrod Goldshtrom
DVDiana Vargas
Diana Vargas
AVAngelica Vasquez
Angelica Vasquez
FKFaith Kim
Faith Kim
KDKinjal Desai
Kinjal Desai
GKGanga Krishnamurthy
Ganga Krishnamurthy
Background: Our understanding of the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pregnancies and perinatal outcomes is limited. The clinical course of neonates born to women who acquired coronavirus disease 2019 (COVID-19) during their pregnancy has been previously described. However, the course of neonates born with complex congenital malformations during the COVID-19 pandemic is not known. Methods: We report a case series of seven neonates with congenital heart and lung malformations born to women who tested positive for SARS-CoV-2 during their pregnancy at a single academic medical center in New York City. Results: Six infants had congenital heart disease and one was diagnosed with congenital diaphragmatic hernia. In all seven infants, the clinical course was as expected for the congenital lesion. None of the seven exhibited symptoms generally associated with COVID-19. None of the infants in our case series tested positive by nasopharyngeal test for SARS-CoV-2 at 24 hours of life and at multiple points during their hospital course. Conclusions: In this case series, maternal infection with SARS-CoV-2 during pregnancy did not result in adverse outcomes in neonates with complex heart or lung malformations. Neither vertical nor horizontal transmission of SARS-CoV-2 was noted.

1 December 2020 in Early Human Development
Verified
Journal Article
Closed access
NGNimrod Goldshtrom
Nimrod Goldshtrom
JIJoseph R. Isler
Joseph R. Isler
RSRakesh Sahni
Rakesh Sahni

6 January 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
ABAsaad G. Beshish
Asaad G. Beshish
DKDavid M. Kwiatkowski
David M. Kwiatkowski
NSNathaniel Sznycer‐Taub
Nathaniel Sznycer‐Taub
JCJohn M. Costello
John M. Costello
AJAndrew Jergel
Andrew Jergel
CMChristopher W. Mastropietro
Christopher W. Mastropietro
Background: Exposure to supraphysiologic oxygen concentrations, or hyperoxia, during neonatal cardiopulmonary bypass (CPB) has been associated with worse outcomes in single‐center studies. We aimed to describe variation in oxygen exposure during CPB and determine if hyperoxia is associated with worse outcomes in a multicenter cohort of neonates undergoing cardiac surgery. Methods: We conducted a retrospective study of neonates who underwent surgery with CPB between January 2021 and December 2022 at 29 centers. Primary outcomes were operative mortality and major adverse cardiovascular events, which included cardiopulmonary resuscitation, extracorporeal support, stroke, and mortality. Logistic regression assessed the associations between median partial pressure of oxygen in arterial blood (PaO 2 ) during CPB and outcomes in the entire cohort and subset of patients with single‐ventricle (SV) anatomy. Results: We analyzed 1175 neonates, including 357 with SV anatomy. Median PaO 2 during CPB was 296 mm Hg (range: 54–800), with significant variation across centers ( P <0.001). There were 54 deaths (5%) and 203 major adverse cardiovascular events (17%). No patients with PaO 2 221 mm Hg demonstrated modest mortality prediction (96% sensitivity, 19% specificity). In multivariable analysis, before adjustment for center, PaO 2 >221 mm Hg was significantly associated with mortality and major adverse cardiovascular events in all patients and patients with SV anatomy. After adjustment for center, associations between hyperoxia and mortality ( P =0.053) or major adverse cardiovascular events ( P =0.08) were not significant in the entire cohort but remained significant in patients with SV anatomy. Conclusions: We observed significant variation in oxygen exposure during neonatal CPB across centers and significant associations between hyperoxia and worse outcomes, particularly in neonates with SV anatomy.